Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pathogen toxins are molecules, typically proteins or peptides, produced by pathogenic microorganisms (such as bacteria, fungi, and some viruses) that cause harmful effects in host organisms. They play a crucial role in microbial virulence, assisting pathogens in colonization, immune system evasion, nutrient acquisition, and host tissue destruction[1][3]. The term encompasses diverse classes, including exotoxins (secreted proteins like diphtheria toxin, cholera toxin), endotoxins (cell wall components such as Gram-negative lipopolysaccharide), pore-forming toxins (e.g., Staphylococcus aureus α-toxin), superantigens (potently activating T cells, e.g., staphylococcal enterotoxins), and enzymatic toxins (e.g., botulinum neurotoxin, shiga toxin). Each toxin typically has a highly specific mode of action, often targeting particular host proteins or processes to disrupt cell function, immunity, or induce cell death[3][7]. Given the diversity of this class, research and therapeutic strategies are usually tailored to individual toxins rather than the class as a whole. This is a non-canonical, over-broad entity; for therapeutic and scientific purposes, more specific names (e.g., "Cholera toxin", "Botulinum neurotoxin type A", "Staphylococcal enterotoxin B") should be used[1][3][7].
Enzymatic modification of host proteins (e.g., ADP-ribosylation, cleavage); Pore formation in cell membranes, leading to cell lysis; Receptor binding and signaling disturbance (e.g., superantigenic activation of T cells); Inhibition of cellular processes (e.g., protein or nucleic acid synthesis inhibition)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pathogen toxin.